Immune changes in patients with colorectal cancer treated by adjuvant therapy with monoclonal antibody 17-1A: A pilot studyTSITSILONIS, O. E; TSAVARIS, N. B; KOSMAS, C et al.Journal of chemotherapy. 2003, Vol 15, Num 3, pp 387-393, issn 1120-009X, 7 p.Article

Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladderSAXENA, Sunita; AGRAWAL, Usha; AGARWAL, Abhilasha et al.BJU international (Papier). 2006, Vol 98, Num 5, pp 1012-1017, issn 1464-4096, 6 p.Article

Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effectiveBADER, P; KREYENBERG, H; GRUHN, B et al.Bone marrow transplantation (Basingstoke). 2004, Vol 33, Num 8, pp 815-821, issn 0268-3369, 7 p.Article

Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCCEL ANSARY, Mervat; MOGAWER, Sherif; SAMAH ABD ELHAMID et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 1, pp 39-48, issn 0171-5216, 10 p.Article

Adjuvant immunotherapy for solid tumors: from promise to clinical applicationMOCELLIN, Simone; ROSSI, Carlo R; LISE, Mario et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 11-12, pp 583-595, issn 0340-7004, 13 p.Article

Expression of melanoma-antigen-A (MAGE-A) in disseminated tumor cells in regional lymph nodes of patients with operable non-small cell lung cancerDANGO, Sebastian; XIAO TAO WANG; GOLD, Monika et al.Lung cancer. 2010, Vol 67, Num 3, pp 290-295, issn 0169-5002, 6 p.Article